Linking mutated primary structure of adrenoleukodystrophy protein with X-linked adrenoleukodystrophy

Computer Methods in Biomechanics and Biomedical Engineering

Volumn 13, Issue 3, 2010, Pages 403-411

  Yan, Shaomin ^a   Wu, Guang ^b  

^a Guangxi Academy of Sciences   (Taiwan)

^b DreamSciTech Consulting   (Taiwan)

Author keywords

Adrenoleukodystrophy; Amino acid; Bayes law; Cross impact analysis; Distribution probability; Mutation

Indexed keywords

ABC TRANSPORTER; ABCD1 PROTEIN, HUMAN; AMINO ACID;

ADRENOLEUKODYSTROPHY; ARTICLE; CHEMISTRY; GENETIC LINKAGE; GENETICS; HUMAN; MUTATION; PROBABILITY;

ADRENOLEUKODYSTROPHY; AMINO ACIDS; ATP-BINDING CASSETTE TRANSPORTERS; GENETIC LINKAGE; HUMANS; MUTATION; PROBABILITY;

EID: 77954685759     PISSN: 10255842     EISSN: 14768259     Source Type: Journal    
DOI: 10.1080/10255840903279974     Document Type: Article

References (53)

1. Andraos J. 2008. Kinetic plasticity and the determination of product ratios for kinetic schemes leading to multiple products without rate laws: new methods based on directed graphs. Can J Chem. 86:342-357.
2. Bezman L, Moser AB, Raymond GV, Rinaldo P, Watkins PA, Smith KD, Kass NE, Moser HW. 2001. Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann Neurol. 49:512-517.
3. Chou KC. 1989. Low-frequency resonance and cooperativity of hemoglobin. Trends Biochem Sci. 14:212.
4. Chou KC. 1992. Energy-optimized structure of antifreeze protein and its binding mechanism. J Mol Biol. 223:509-517.
5. Chou KC. 1995. A novel approach to predicting protein structural classes in a (20-1)-D amino acid composition space. Proteins Struct Funct Genet. 21:319-344.
6. Chou KC. 1996. Review: prediction of HIV protease cleavage sites in proteins. Anal Biochem. 233:1-14.
7. Chou KC. 2004. Structure bioinformatics and its impact to biomedical science. Curr Med Chem. 11:2105-2134.
8. Chou KC. 2005. Using amphiphilic pseudo amino acid composition to predict enzyme subfamily classes. Bioinformatics. 21:10-19.
9. Chou KC, Elrod DW. 2002. Bioinformatical analysis of G-protein-coupled receptors. J Proteome Res. 1:429-433.
10. Chou KC, Shen HB. 2007. Euk-mPLoc: a fusion classifier for large-scale eukaryotic protein subcellular location prediction by incorporating multiple sites. J Proteome Res. 6:1728-1734.
11. Chou KC, Shen HB. 2008. Cell-PLoc: a package of web-servers for predicting subcellular localization of proteins in various organisms. Nat Prot. 3:153-162.
12. Chou KC, Zhou GP. 1982. Role of the protein outside active site on the diffusion-controlled reaction of enzyme. J Am Chem Soc. 104:1409-1413.
13. Chou KC, Zhang CT, Maggiora GM. 1994. Solitary wave dynamics as a mechanism for explaining the internal motion during microtubule growth. Biopolymers. 34:143-153.
14. Dubois-Dalcq M, Feigenbaum V, Aubourg P. 1999. The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder. Trends Neurosci. 22:4-12.
15. Dvorakova L, Storkanova G, Unterrainer G, Hujova J, Kmoch S, Zeman J, Hrebicek M, Berger J. 2001. Eight novel ABCD1 gene mutations and three polymorphisms in patients with X-linked adrenoleukodystrophy: the first polymorphism causing an amino acid exchange. Hum Mutat. 18:52-60.
16. Eichler FS, Barker PB, Cox C, Edwin D, Ulug AM, Moser HW, Raymond GV. 2002. Proton MR spectroscopic imaging predicts lesion progression on MRI in X-linked adrenoleukodystrophy. Neurology. 58:901-907.
17. Enzer S. 1970. Cross-impact techniques in technology assessment. Futures. 4:30-51.
18. Feller W. 1968. An introduction to probability theory and its applications. Vol. I. 3rd ed., New York, NY: Wiley. p. 34-40.
19. Gloeckner CJ, Mayerhofer PU, Landgraf P, Muntau AC, Holzinger A, Gerber JK, Kammerer S, Adamski J, Roscher AA. 2000. Human adrenoleukodystrophy protein and related peroxisomal ABC transporters interact with the peroxisomal assembly protein PEX19p. Biochem Biophys Res Commun. 271:144-150.
20. Gordon TG. 1969. Cross-impact matrices-an illustration of their use for policy analysis. Futures. 2:527-531.
21. Hargrove JL, Greenspan P, Hartle DK. 2004. Nutritional significance and metabolism of very long chain fatty alcohols and acids from dietary waxes. Exp Biol Med. 229:215-226.
22. Kemp S, Pujol A, Waterham HR, van Geel BM, Boehm CD, Raymond GV, Cutting GR, Wanders RJA, Moser HW. 2001. ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations. Hum Mutat. 18:499-515.
23. Lauretti S, Casucci G, Santeusanio F, Angeletti G, Aubourg P, Brunetti P. 1996. Xlinked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients. J Clin Endocrinol Metab. 81:470-474.
24. Lazo D, Contreras M, Hashmi M, Stanley W, Irazu C, Singh T. 1988. Peroxisomal lignoceroyl CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy. Proc Natl Acad Sci USA. 85:7647-7651.
25. Lin A, Ross BD, Harris K, Wong W. 2005. Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making. J Am Soc Exp NeuroTherap. 2:197-214.
26. Lovas K, Husebye ES. 2002. High prevalence and increasing incidence of Addison's disease in western Norway. Clin Endocrinol (Oxf). 56:787-791.
27. Michaelis S, Berkower C. 1995. Sequence comparison of yeast ATP-binding cassette proteins. Cold Spring Harbor Symp Quant Biol. 60:291-307.
28. Migeon BR, Moser HW, Moser AB, Axelman J, Sillence D, Norum RA. 1982. Adrenoleukodystrophy: evidence for X linkage, inactivation selection favoring the mutant allele in the heterozygous cells. Proc Natl Acad Sci USA. 78:5066-5070.
29. Montagna G, Di Biase A, Cappa M, Melone MAB, Piantadosi C, Colabianchi D, Patrono C, Attori L, Cannelli N, Cotrufo R et al., 2005. Identification of seven novel mutations in ABCD1 by a DHPLC-based assay in Italian patients with X-linked adrenoleukodystrophy. Hum Mutat. 25:222.
30. Moser HW, Bergin A, Naidu S, Ladenson PW. 1991. Adrenoleukodystrophy. Endocrinol Metab Clin North Am. 20:297-318.
31. Moser H, Dubye P, Fatemi A. 2004. Progress in X-linked adrenoleukodystrophy. Curr Opin Neurol. 17:263-269.
32. Ohno T, Tsuchida H, Fukuhara N, Yuasa T, Harayama H, Tsuji S, Miyatake T. 1984. Adrenoleukodystrophy: a clinical variant presenting as olivopontocerebellar atrophy. J Neurol. 231:167-169.
33. Roerig P, Mayerhofer P, Holzinger A, Gaertner J. 2001. Characterization and functional analysis of the nucleotide binding fold in human peroxisomal ATP binding cassette transporters. FEBS Lett. 492:66-72.
34. Sage AP. 1977. Methodology for large-scale systems. New York, NY: McGraw-Hill. pp. 165-203.
35. Schrier RW. 2006. Body water homeostasis: clinical disorders of urinary dilution and concentration. J Am Soc Nephrol. 17:1820-1832.
36. Shen HB, Chou KC. 2007. EzyPred: a top-down approach for predicting enzyme functional classes and subclasses. Biochem Biophys Res Commun. 364:53-59.
37. Shen HB, Song JN, Chou KC. 2009. Prediction of protein folding rates from primary sequence by fusing multiple sequential features. J Biomed Sci Eng. 2:136-143.
38. Siemerling E, Creudzfeldt HG. 1923. Brozzkrankheit und sclerosierende encephalomyelitis. Arch Fr Psychiatr. 68:217-244.
39. Spurek M, Taylor-Gjevre R, van Uum S, Khandwala HM. 2004. Adrenomyeloneuropathy as a cause of primary adrenal insufficiency and spastic paraparesis. Can Med Assoc J. 171:1073-1077.
40. Štefková J, Poledne R, Hubáček JA. 2004. ATP-binding cassette (ABC) transporters in human metabolism and diseases. Physiol Res. 53:235-243.
41. Steinman L. 2006. Four Easy pieces interconnections between tissue injury, intermediary metabolism, autoimmunity, and chronic degeneration. Proc Am Thorac Soc. 3:484-488.
42. van Geel BM, Assies J, Weverling GJ, Barth PG. 1994. Predominance of the adrenomyeloneuropathy phenotype of X-linked adrenoleukodystrophy in the Netherlands. Neurology. 44:2243-2246.
43. van Geel BM, Assies J, Wanders RJA, Barth PG. 1997. X-linked adrenoleukodystrophy: clinical presentation, diagnosis and therapy. J Neurol Neurosurg Psychiatry. 63:4-14.
44. Wanders RJA, Tager JA. 1991. Peroxisomal fatty acid β-oxidation in adrenoleukodystrophy. Dev Neurosci. 13:262-266.
45. Wikipedia-the free encyclopedia. 2008. Bayes' theorem.en. wikipedia.org/wiki/Bayes'_theorem.
46. Wu G. 2000. Application of cross-impact analysis to the relationship between aldehyde dehydrogenase 2 and flushing. Alcohol Alcohol. 35:55-59.
47. Wu G, Yan S. 2002. Randomness in the primary structure of protein: methods and implications. Mol Biol Today. 3:55-69.
48. Wu G, Yan S. 2006. Mutation trend of hemagglutinin of influenza A virus: a review from computational mutation viewpoint. Acta Pharmacol Sin. 27:513-526.
49. Wu G, Yan S. 2008. Lecture notes on computational mutation. New York, NY: Nova Science Publishers.
50. Xiao X, Chou KC. 2007. Digital coding of amino acids based on hydrophobic index. Protein Pept Lett. 14:871-875.
51. Xiao X, Shao S, Ding Y, Huang Z, Huang Y, Chou KC. 2005. Using complexity measure factor to predict protein subcellular location. Amino Acids. 28:57-61.
52. Xiao X, Lin WZ, Chou KC. 2008. Using grey dynamic modeling and pseudo amino acid composition to predict protein structural classes. J Comput Chem. 29:2018-2024.
53. Xiao X, Wang P, Chou KC. 2009. Predicting protein quaternary structural attribute by hybridizing functional domain composition and pseudo amino acid composition. J Appl Crystallogr. 42:169-173.